Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

NMTC vs AAPU: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

NMTC Wins Head-to-Head Institutional Verdict (5–0 across 6 Pillars · 5–3 Matrix Metrics)

NMTC Overall Winner 6-Pillar Tally: NMTC 5 – 0 AAPU (1 Tie) Matrix Metrics: NMTC 5 – 3 AAPU

As of Nov 20, 2026, NeuroOne Medical Technologies Corporation (NMTC) is the stronger overall head-to-head candidate over Direxion Shares ETF Trust Direxion Daily AAPL Bull 2X Shares (AAPU) in the Tradestie Institutional Equity Comparison Engine, winning 5–3 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). NMTC carries a Unified Composite Score of 45.5/100 (HOLD) at $0.65 (N/M Forward P/E, -63.4% operating margin), whereas AAPU carries 54.2/100 (HOLD) at $45.91 (N/M Forward P/E, N/A operating margin).

  • Composite vs. Pillar Nuance: While AAPU currently prints a higher short-term Unified Composite Score (54.2/100 HOLD vs. NMTC 45.5/100 HOLD), NMTC captures the overall institutional head-to-head verdict (5–3 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (-63.4% vs. N/A operating margin) and revenue trajectory (+16.3% vs. N/A YoY).
  • Technical & Structure Timing Caution: NMTC is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 31.2); meanwhile AAPU trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 45.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About NMTC vs AAPU
NMTC NASDAQ Head-to-Head Winner
NeuroOne Medical Technologies Corporation Common Stock
Surgical & Medical Instruments & Apparatus
$0.65
-3.38% 1D
Market Cap $6.1M
TTM Revenue $12M
Forward P/E N/M
Beta / 30D Vol 1.55β · 105% Vol
Unified Composite Score
45.5 / 100 HOLD
Tech 33.0 Fund 51.0 Flow 60.0 Mom 64.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -28.4%), weak momentum, RSI 31
RSI-14: 31.2 · SMA20: $0.83 · SMA50: $1.03
AAPU NASDAQ
Direxion Shares ETF Trust Direxion Daily AAPL Bull 2X Shares
Institutional Equity
$45.91
-3.71% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 1.06β · 54% Vol
Unified Composite Score
54.2 / 100 HOLD
Tech 42.0 Fund 43.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 45
RSI-14: 45.4 · SMA20: $47.48 · SMA50: $46.32

6-Pillar Scorecard Institutional Category Breakdown (NMTC 5 – 0 AAPU)

Columns: Metric · NMTC · AAPU
1. Valuation Multiples NMTC
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue 0.3x N/M
2. Growth & Scale NMTC
Revenue Growth (YoY) +16.3% N/A
Earnings Growth (YoY) +0.0% N/A
TTM Revenue (USD) $12M N/A
Market Cap $6.1M N/A
3. Profitability & Quality NMTC
Gross Margin 23.0% N/A
Operating Margin -63.4% N/A
Net Profit Margin -59.7% N/A
Return on Equity (ROE) -124.7% N/A
4. Balance Sheet & Cash Flow NMTC
Cash Generation (TTM) -$7.6M N/A
Cash Flow Margin -60.7% N/A
Net Cash / Leverage $2.6M Net Cash N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning NMTC
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) 38.2% (11th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Neutral
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Medical Devices Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: NMTC (5) vs AAPU (3)
Institutional Metric NMTC AAPU Criterion Row Edge
Market Capitalization
Scale
$6.1M N/A Larger Scale NMTC
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+16.3% N/A Higher Growth NMTC
Operating Margin (TTM)
Profitability
-63.4% N/A Higher Margin NMTC
Net Profit Margin
Profitability
-59.7% N/A Higher Margin NMTC
Return on Equity (ROE)
Capital Efficiency
-124.7% N/A Higher ROE NMTC
52-Week Range Position
Momentum
2% ($1–$5) 79% ($26–$51) Stronger Trend AAPU
Beta / 30D Volatility
Risk Regime
1.55β · 105% Vol 1.06β · 54% Vol Lower Realized Risk AAPU
Unified Institutional Score
Composite Signal
45.5 / 100 (HOLD) 54.2 / 100 (HOLD) Higher Composite AAPU
Trailing 12M Revenue (USD)
Operating Scale
$12M N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
23.0% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.3x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$7.6M ($2.6M Net Cash) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon AAPU +29.11 pp
NMTC: -33.46% · AAPU: -4.35%
3M Horizon AAPU +86.92 pp
NMTC: -69.53% · AAPU: +17.39%
6M Horizon AAPU +94.91 pp
NMTC: -82.33% · AAPU: +12.58%
1Y Horizon AAPU +25.98 pp
NMTC: +3.49% · AAPU: +29.47%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NMTC vs AAPU. Trailing 12-month operating profitability (NMTC -63.4% vs AAPU N/A) and valuation multiples (NMTC N/M vs AAPU N/M Forward P/E) are benchmarked directly in Pillar 4 below.

NMTC ADR TTM Benchmark FX-Normalized USD
TTM Revenue$12M
Gross Margin23.0%
Op. Margin-63.4%
ROE / Fwd P/E-124.7% · N/M
AAPU ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
NMTC UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact NMTC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
AAPU UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 38.2%
IV Percentile 11th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact AAPU Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
NMTC Moat Profile Cyclical / Execution-Driven Positioning
Medical Devices Operator
Competes within the Medical Devices value chain with $6.1M market capitalization and -63.4% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
AAPU Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ NMTC vs AAPU Key Questions & Quantitative Answers

As of Nov 20, 2026, NeuroOne Medical Technologies Corporation (NMTC) is the stronger overall head-to-head candidate over Direxion Shares ETF Trust Direxion Daily AAPL Bull 2X Shares (AAPU) in the Tradestie Institutional Equity Comparison Engine, winning 5–3 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). NMTC carries a Unified Composite Score of 45.5/100 (HOLD) at $0.65 (N/M Forward P/E, -63.4% operating margin), whereas AAPU carries 54.2/100 (HOLD) at $45.91 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While AAPU currently prints a higher short-term Unified Composite Score (54.2/100 HOLD vs. NMTC 45.5/100 HOLD), NMTC captures the overall institutional head-to-head verdict (5–3 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (-63.4% vs. N/A operating margin) and revenue trajectory (+16.3% vs. N/A YoY). Technical & Structure Timing Caution: NMTC is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 31.2); meanwhile AAPU trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 45.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

NMTC leads the Growth & Scale pillar: NMTC posts +16.3% YoY revenue growth and +0.0% YoY earnings growth on $12M TTM revenue (23.0% gross margin, -63.4% operating margin), compared with AAPU at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, NMTC generates $12M in USD-normalized revenue versus N/A for AAPU. In operating R&D and SG&A reinvestment, NMTC deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for AAPU.

NMTC screens cheaper on headline valuation multiples. NMTC trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.3x EV/Revenue (-60.7% FCF margin), whereas AAPU trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against NMTC (-124.7% ROE) versus AAPU (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, NMTC carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.55β · 105% Vol realized risk). By comparison, AAPU carries 38.2% implied volatility (11th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.06β · 54% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.